PKP2缺失导致核膜完整性丧失与氧化产物增加引发DNA损伤:ARVC的分子基础
研究通过高分辨率质谱、RNA测序和电镜分析PKP2突变ARVC患者右心室活检样本,发现核膜完整性丧失、DNA损伤分子特征及电子传递链转录本减少。小鼠和iPSC来源心肌细胞模型重现该表型,honokiol可减少氧化应激和DNA损伤并保护右心室功能。
要点
- PKP2突变ARVC患者心肌显示核膜完整性丧失和DNA损伤分子特征。
- PKP2缺失导致电子传递链转录下调及氧化产物增加,机械应激进一步加重。
- Honokiol通过增加SIRT3活性减少氧化应激和DNA损伤,保护右心室功能。
核心结论
- 核膜完整性丧失及继发DNA损伤是ARVC分子病理的关键基础。
- 电子传递链蛋白转录下调是早于左室射血分数下降的早期事件,与氧化产物增加相关。
- 限制氧化产物形成的治疗可能限制ARVC中的DNA损伤。
研究设计与样本
- 对PKP2突变且左室射血分数>45%的ARVC患者右心室活检样本进行高分辨率质谱、RNA测序和透射电镜分析,健康亲属样本为对照。
- 在心脏特异性Pkp2敲除小鼠(左室射血分数保留时)及人诱导多能干细胞来源的PKP2缺陷心肌细胞中进行影像学和生化实验。
主要发现
- ARVC患者样本显示核膜完整性丧失、DNA损伤分子特征及电子传递链转录本缺陷。
- 心脏特异性Pkp2敲除小鼠出现核膜完整性丧失,导致DNA损伤和氧化产物(O2.-和H2O2)增加,机械应激(异丙肾上腺素或运动)下进一步增加。
- PKP2缺陷细胞释放H2O2至细胞外环境,以旁分泌方式导致邻近心肌细胞DNA损伤和氧化产物增加。
- Honokiol增加SIRT3活性,在体外和体内减少氧化产物水平和DNA损伤,减少右心室游离壁胶原丰度,并保护右心室功能。
临床怎么用
- PKP2突变ARVC患者早期(左室射血分数保留时)已存在核膜完整性丧失和DNA损伤。
- 限制氧化产物形成的治疗策略可能用于限制ARVC中的DNA损伤。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Arrhythmogenic right ventricular cardiomyopathy (ARVC) is characterized by high propensity to life-threatening arrhythmias and progressive loss of heart muscle. More than 40% of reported genetic variants linked to ARVC reside in the PKP2 gene, which encodes the PKP2 protein (plakophilin-2). METHODS: We describe a comprehensive characterization of the ARVC molecular landscape as determined by high-resolution mass spectrometry, RNA sequencing, and transmission electron microscopy of right ventricular biopsy samples obtained from patients with ARVC with PKP2 mutations and left ventricular ejection fraction >45%. Samples from healthy relatives served as controls. The observations led to experimental work using multiple imaging and biochemical techniques in mice with a cardiac-specific deletion of Pkp2 studied at a time of preserved left ventricular ejection fraction and in human induced pluripotent stem cell-derived PKP2-deficient myocytes. RESULTS: Samples from patients with ARVC present a loss of nuclear envelope integrity, molecular signatures indicative of increased DNA damage, and a deficit in transcripts coding for proteins in the electron transport chain. Mice with a cardiac-specific deletion of Pkp2 also present a loss of nuclear envelope integrity, which leads to DNA damage and subsequent excess oxidant production (O2.- and H2O2), the latter increased further under mechanical stress (isoproterenol or exercise). Increased oxidant production and DNA damage is recapitulated in human induced pluripotent stem cell-derived PKP2-deficient myocytes. Furthermore, PKP2-deficient cells release H2O2 into the extracellular environment, causing DNA damage and increased oxidant production in neighboring myocytes in a paracrine manner. Treatment with honokiol increases SIRT3 (mitochondrial nicotinamide adenine dinucleotide-dependent protein deacetylase sirtuin-3) activity, reduces oxidant levels and DNA damage in vitro and in vivo, reduces collagen abundance in the right ventricular free wall, and has a protective effect on right ventricular function. CONCLUSIONS: Loss of nuclear envelope integrity and subsequent DNA damage is a key substrate in the molecular pathology of ARVC. We show transcriptional downregulation of proteins of the electron transcript chain as an early event in the molecular pathophysiology of the disease (before loss of left ventricular ejection fraction <45%), which associates with increased oxidant production (O2.- and H2O2). We propose therapies that limit oxidant formation as a possible intervention to restrict DNA damage in ARVC.
引用
- Pérez-Hernández M, van Opbergen CJM, Bagwan N, et al. Loss of Nuclear Envelope Integrity and Increased Oxidant Production Cause DNA Damage in Adult Hearts Deficient in PKP2: A Molecular Substrate of ARVC. Circulation. 2022. PMID: 35959657. doi:10.1161/CIRCULATIONAHA.122.060454
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。